Form 4: Clorox Director Increases Stake via DSU Acquisitions

Sentiment:

Insider Transaction Report


Clorox Director Matthew J. Shattock increased his beneficial ownership of Deferred Stock Units through routine dividend reinvestment and receipt of quarterly director's fees.

Summary

  • Matthew J. Shattock, a Director of The Clorox Company, acquired additional Deferred Stock Units (DSUs).
  • On August 29, 2025, 172.9087 DSUs were acquired through dividend reinvestment as part of the Independent Directors' Deferred Compensation Plan. The price of these derivative securities was $0.0000.
  • On September 30, 2025, an additional 415.6529 DSUs were received in lieu of quarterly director's fees. The price of these derivative securities was $0.0000.
  • Following these transactions, Mr. Shattock's direct beneficial ownership of DSUs increased to 17,070.6618.
  • These DSUs are convertible on a 1-for-1 basis into Clorox common stock and will be settled upon Mr. Shattock's retirement or termination of service as a Director.

Sentiment

Score: 6

Explanation: The filing indicates a director's routine increase in equity ownership through compensation and dividend reinvestment, which is generally viewed as a neutral to slightly positive sign of alignment with shareholder interests, but does not reflect new strategic or operational developments.

Positives

  • Director Matthew J. Shattock increased his beneficial ownership in the company, aligning his interests further with shareholders.
  • The acquisition of Deferred Stock Units through dividend reinvestment demonstrates a continued commitment to holding company equity.
  • Receiving director's fees in DSUs rather than cash indicates confidence in the company's future performance.

Negatives

  • NA

Risks

  • NA

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance, focusing instead on past insider transactions.

Management Comments

  • NA

Industry Context

This Form 4 filing details a routine insider transaction for a director of The Clorox Company and does not provide broader industry context or trends.

Comparison to Industry Standards

  • NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation Structure DetailThe filing details the Independent Directors' Deferred Compensation Plan, under which Deferred Stock Units are acquired through dividend reinvestment and in lieu of quarterly director's fees.N/AThis plan aligns director compensation with shareholder interests by deferring equity settlement until termination of service, promoting long-term commitment.

Legal Proceedings

  • NA

Related Party Transactions

  • The acquisition of Deferred Stock Units by Director Matthew J. Shattock as part of his compensation and dividend reinvestment plan constitutes a related party transaction.

Stakeholder Impact

  • Shareholders: Increased alignment of a director's interests with shareholders due to higher equity ownership.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Next Steps

  • The Deferred Stock Units will be settled 100% in Clorox common stock upon the reporting person's retirement or other termination of service as a Director.

Key Dates

DateDescription
08/29/2025Acquisition of 172.9087 Deferred Stock Units through dividend reinvestment.
09/30/2025Acquisition of 415.6529 Deferred Stock Units in lieu of quarterly director's fees.
10/02/2025Date the Form 4 was signed by Attorney-in-Fact Jinho Joo.

Keywords

Clorox, CLX, Form 4, Insider Transaction, Deferred Stock Units, Director Compensation, Equity Ownership, Dividend Reinvestment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.